Patrick McEnany is the CEO and co-founder of Catalyst Pharmaceuticals. The company is betting its future on a drug called Firdapse, which is used to treat a rare neurological disease called LEMS.
Patrick McEnany is the CEO and co-founder of Catalyst Pharmaceuticals. The company is betting its future on a drug called Firdapse, which is used to treat a rare neurological disease called LEMS. PETER ANDREW BOSCH MIAMI HERALD STAFF
Patrick McEnany is the CEO and co-founder of Catalyst Pharmaceuticals. The company is betting its future on a drug called Firdapse, which is used to treat a rare neurological disease called LEMS. PETER ANDREW BOSCH MIAMI HERALD STAFF

Business Monday

July 18, 2015 3:00 PM

The big gamble: Catalyst Pharmaceuticals of Coral Gables bets on new drug for rare disease

  Comments  

Videos